Indication
subtype-b
1 clinical trial
2 products
Clinical trial
A Pilot Open Label Phase I Trial to Evaluate the Safety and the Tolerability of a Combination of Two HIV-1 Inducers in HIV+ Sub-type B Patients Under cART With Undetectable Viral LoadStatus: Recruiting, Estimated PCD: 2026-04-15
Product
DecitabineProduct
Romidepsin